Henry Schein Inc HSIC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
GoTu and Henry Schein Announce Strategic Partnership to Strengthen Dental Workforce Support Nationwide
-
Henry Schein Announces the Election of William K. “Dan” Daniel as Independent Chairman of the Board
-
Henry Schein One Releases 2026 Catalyst Index, Revealing Clinical Performance as the Primary Driver of Growth
-
Henry Schein Reports First Quarter 2026 Financial Results
-
Henry Schein to Participate in Upcoming Investor Conferences in May
-
Dentrix Ascend Introduces Next Generation Clinical Workflow Built with AWS
-
Dentrix Ascend Opens Its MCP Layer, Bringing AI Agents and a Custom Build Platform to Dental Practices
-
Henry Schein to Webcast First Quarter 2026 Conference Call on Tuesday, May 5, 2026, at 8:00 A.M. ET
Trading Information
- Previous Close Price
- $84.40
- Day Range
- $84.59–85.84
- 52-Week Range
- $61.95–89.29
- Bid/Ask
- $83.06 / $88.09
- Shares Outstanding
- 113.92M
- Market Cap
- $9.77B
- Volume/Avg
- 1M / 1M
Key Statistics
- Price/Earnings (Normalized)
- 16.69
- Price/Sales
- 0.77
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 5.77%
Company Profile
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 25,000
- Website
- https://www.henryschein.com
Valuation
|
Metric
|
HSIC
|
|---|---|
Price/Earnings (Normalized) | 16.69 |
Price/Book Value | 3.01 |
Price/Sales | 0.77 |
Price/Cash Flow | 13.16 |
Price/Earnings
HSIC
Financial Strength
|
Metric
|
HSIC
|
|---|---|
Quick Ratio | 0.56 |
Current Ratio | 1.36 |
Interest Coverage | 4.27 |
Quick Ratio
HSIC
Profitability
|
Metric
|
HSIC
|
|---|---|
Return on Assets (Normalized) | 4.80% |
Return on Equity (Normalized) | 15.88% |
Return on Invested Capital (Normalized) | 7.49% |
Return on Assets
HSIC
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|pfXN>!% | LOCK|D@P> | $95B | |||
| Cencora Inc
COR
| LOCK|vMhP!fj | LOCK|gSmv | $60B | |||
| Cardinal Health Inc
CAH
| LOCK|&>fJ&G | LOCK|?rfb | $55B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|@z#&y | $23B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|^$j | $8B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|rH | $7B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|s#? | $7B | |||
| Medipal Holdings Corp ADR
MAHLY
| — | LOCK|&d | $3B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|$m | $3B |
United States